Cullinan Therapeutics News, Cullinan Therapeutics Quote, CGEM Quote

Cullinan Therapeutics (NQ:CGEM) Delayed: 18.89 --0 (-0%)

Prev. Close

$18.89

Open

$18.89

52 Wk High

$0.19

52 Wk Low

$0.03

Day High

$18.89

Day Low

$18.89

P/E

N/A

EPS

$0.00

Volume

Apr 24, 2024 05:50 PM Form SC 13G Cullinan Therapeutics, Filed by: Flynn James E
Apr 24, 2024 10:09 AM Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advance
Apr 19, 2024 06:50 AM Cullinan Oncology Inc. (CGEM) PT Raised to $36 at Wedbush
Apr 17, 2024 06:46 AM Cullinan Oncology Inc. (CGEM) PT Lowered to $29 at H.C. Wainwright
Apr 17, 2024 05:08 AM Cullinan Oncology Inc. (CGEM) PT Raised to $30 at BTIG
Apr 16, 2024 12:34 PM Cullinan Oncology Inc. (CGEM) PT Raised to $26 at Jones Trading
Apr 16, 2024 07:15 AM Form 8-K Cullinan Therapeutics, For: Apr 15
Apr 16, 2024 07:00 AM Cullinan Therapeutics (CGEM) Announces Strategic Expansion into Autoimmune Diseases
Apr 16, 2024 07:00 AM Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
Apr 16, 2024 06:59 AM Cullinan Therapeutics (CGEM) Announces $280M Placement at $19/sh

Entities mentioned with CGEM